作者: Weinstein David S , Xiao Zili , Yang Michael G
DOI:
关键词:
摘要: Novel non-steroidal compounds are provided which useful in treating diseases or disorders associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-kB activity, including metabolic and inflammatory immune disorders, having structure formula (I): an enantiomer, diastereomer, tautomer thereof, a prodrug ester pharmaceutically-acceptable salt variables as defined specification.